Hostname: page-component-848d4c4894-xm8r8 Total loading time: 0 Render date: 2024-06-23T19:33:30.230Z Has data issue: false hasContentIssue false
  • English
  • Français

Performance of the Present-on-Admission Indicator for Clostridium difficile Infection

Published online by Cambridge University Press:  20 March 2015

Amy L. Pakyz ,
Julie A. Patterson ,
Christine Motzkus-Feagans ,
Samuel F. Hohmann ,
Michael B. Edmond  and
Kate L. Lapane
Amy L. Pakyz*
Affiliation:
Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia
Julie A. Patterson
Affiliation:
Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia
Christine Motzkus-Feagans
Affiliation:
Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts
Samuel F. Hohmann
Affiliation:
University Health System Consortium, Chicago, Illinois
Michael B. Edmond
Affiliation:
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Kate L. Lapane
Affiliation:
Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts
*
Address correspondence to Amy Pakyz, PharmD, PhD, 410 N. 12th St, PO Box 980533, Richmond, VA 23298-0533 (apakyz@vcu.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

The performance of a hospital- and community-onset Clostridium difficile infection definition using administrative data with a present-on-admission indicator was compared with definitions using clinical surveillance. For hospital-onset C. difficile infection, there was moderate sensitivity (68%) and high specificity (93%); for community-onset, sensitivity and specificity were high (both 85%).

Infect Control Hosp Epidemiol 2015;36(7):838–840

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 7 , July 2015 , pp. 838 - 840
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. McDonald, LC, Coignard, B, Dubberke, E, Song, X, Horan, T. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140–145.Google Scholar
2. Dubberke, ER, Reske, KA, McDonald, LC, Fraser, VJ. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis 2006;12:1576–1579.CrossRefGoogle ScholarPubMed
3. Centers for Medicare and Medicaid Services. Hospital-acquired conditions (present on admission indicator). http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalAcqCond/index.html?redirect=/hospitalacqcond. Accessed October 15, 2014.Google Scholar
4. Jiang, Y, Viner-Brown, S, Baier, R. Burden of hospital-onset Clostridium difficile infection in patients discharged from Rhode Island hospitals, 2010-2011: application of present on admission indicators. Infect Control Hosp Epidemiol 2013;34:700–708.CrossRefGoogle ScholarPubMed
5. Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:628–645.Google Scholar
6. Schmiedeskamp, M, Harpe, S, Polk, R, Oinonen, M, Pakyz, A. Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:1070–1076.CrossRefGoogle ScholarPubMed
7. Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010;31:1030–1037.Google Scholar
8. Wilcox, MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 2012;18:13–20.CrossRefGoogle ScholarPubMed